Latest Quarter
2025-12-31
Boston Scientific Corporation (0HOY.L)
Revenue
$5.3B
Net Income
$668M
Operating Margin
22.8%
Free Cash Flow
$2.6B
Debt / Assets
44.1%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | 5,286,000,000 | 5,065,000,000 | 5,061,000,000 | 4,663,000,000 |
| Cost of Revenue | 1,348,000,000 | 1,523,000,000 | 1,637,000,000 | 1,713,000,000 |
| Gross Profit | 3,937,000,000 | 3,542,000,000 | 3,424,000,000 | 2,950,000,000 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 1,834,000,000 | 1,741,000,000 | 1,716,000,000 | 1,597,000,000 |
| Operating Expenses | 2,731,000,000 | 2,492,000,000 | 2,605,000,000 | 2,054,000,000 |
| Operating Income | 1,206,000,000 | 1,050,000,000 | 819,000,000 | 896,000,000 |
| Interest Expense | 90,000,000 | 87,000,000 | 90,000,000 | 87,000,000 |
| Income Before Tax | 700,000,000 | 939,000,000 | 941,000,000 | 805,000,000 |
| Income Tax Expense | 31,000,000 | 183,000,000 | 146,000,000 | 133,000,000 |
| Net Income | 668,000,000 | 755,000,000 | 793,000,000 | 674,000,000 |
| Per Share | ||||
| EPS | 0.45 | 0.51 | 0.54 | 0.46 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | 20,074,000,000 | 16,747,000,000 | 14,240,000,000 | 12,682,000,000 |
| Cost of Revenue | 6,221,000,000 | 6,480,000,000 | 4,345,000,000 | 4,968,000,000 |
| Gross Profit | 13,853,000,000 | 10,267,000,000 | 9,895,000,000 | 7,714,000,000 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 6,887,000,000 | 5,984,000,000 | 5,190,000,000 | 4,520,000,000 |
| Operating Expenses | 9,882,000,000 | 7,632,000,000 | 7,552,000,000 | 5,890,000,000 |
| Operating Income | 3,971,000,000 | 2,635,000,000 | 2,343,000,000 | 1,824,000,000 |
| Interest Expense | 349,000,000 | 387,000,000 | 265,000,000 | 464,000,000 |
| Income Before Tax | 3,385,000,000 | 2,282,000,000 | 1,985,000,000 | 1,141,000,000 |
| Income Tax Expense | 493,000,000 | 436,000,000 | 393,000,000 | 443,000,000 |
| Net Income | 2,886,000,000 | 1,854,000,000 | 1,593,000,000 | 698,000,000 |
| Per Share | ||||
| EPS | 1.96 | 1.26 | 1.08 | 0.49 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Assets | |||
| Cash and Cash Equivalents | 414,000,000 | 865,000,000 | 1,077,000,000 |
| Short Term Investments | 0 | 0 | 0 |
| Net Receivables | 2,558,000,000 | 2,228,000,000 | 1,970,000,000 |
| Inventory | 2,810,000,000 | 2,484,000,000 | 1,867,000,000 |
| Total Current Assets | 6,920,000,000 | 6,514,000,000 | 5,760,000,000 |
| Property Plant Equipment | 3,744,000,000 | 3,298,000,000 | 2,832,000,000 |
| Goodwill and Intangibles | 23,773,000,000 | 20,390,000,000 | 18,889,000,000 |
| Total Assets | 39,395,000,000 | 35,136,000,000 | 32,469,000,000 |
| Liabilities | |||
| Account Payables | 960,000,000 | 942,000,000 | 862,000,000 |
| Short Term Debt | 1,778,000,000 | 531,000,000 | 20,000,000 |
| Total Current Liabilities | 6,399,000,000 | 4,933,000,000 | 3,803,000,000 |
| Long Term Debt | 9,369,000,000 | 8,961,000,000 | 8,910,000,000 |
| Total Liabilities | 17,392,000,000 | 15,606,000,000 | 14,896,000,000 |
| Shareholders Equity | |||
| Retained Earnings | 2,673,000,000 | 819,000,000 | -750,000,000 |
| Total Shareholders Equity | 21,770,000,000 | 19,282,000,000 | 17,573,000,000 |
| Balance Sheet (Annual) | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Assets | |||
| Cash and Cash Equivalents | 414,000,000 | 865,000,000 | 1,077,000,000 |
| Short Term Investments | 0 | 0 | 0 |
| Net Receivables | 2,558,000,000 | 2,228,000,000 | 1,970,000,000 |
| Inventory | 2,810,000,000 | 2,484,000,000 | 1,867,000,000 |
| Total Current Assets | 6,920,000,000 | 6,514,000,000 | 5,760,000,000 |
| Property Plant Equipment | 3,744,000,000 | 3,298,000,000 | 2,832,000,000 |
| Goodwill and Intangibles | 23,773,000,000 | 20,390,000,000 | 18,889,000,000 |
| Total Assets | 39,395,000,000 | 35,136,000,000 | 32,469,000,000 |
| Liabilities | |||
| Account Payables | 960,000,000 | 942,000,000 | 862,000,000 |
| Short Term Debt | 1,778,000,000 | 531,000,000 | 20,000,000 |
| Total Current Liabilities | 6,399,000,000 | 4,933,000,000 | 3,803,000,000 |
| Long Term Debt | 9,369,000,000 | 8,961,000,000 | 8,910,000,000 |
| Total Liabilities | 17,392,000,000 | 15,606,000,000 | 14,896,000,000 |
| Shareholders Equity | |||
| Retained Earnings | 2,673,000,000 | 819,000,000 | -750,000,000 |
| Total Shareholders Equity | 21,770,000,000 | 19,282,000,000 | 17,573,000,000 |
| Cash Flow Statement (Quarterly) | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | 1,846,000,000 | 1,592,000,000 | 698,000,000 |
| Depreciation & Amortization | 1,269,000,000 | 1,196,000,000 | 1,136,000,000 |
| Stock Based Compensation | 266,000,000 | 233,000,000 | 220,000,000 |
| Change in Working Capital | -462,000,000 | -770,000,000 | -1,005,000,000 |
| Operating Cash Flow | 3,435,000,000 | 2,503,000,000 | 1,526,000,000 |
| Investing Activities | |||
| Capital Expenditure | -790,000,000 | -800,000,000 | -588,000,000 |
| Investments | -790,000,000 | -711,000,000 | -588,000,000 |
| Investing Cash Flow | -5,687,000,000 | -2,574,000,000 | -2,011,000,000 |
| Financing Activities | |||
| Debt Repayment | 1,827,000,000 | -4,000,000 | -165,000,000 |
| Common Stock Issued/Repurchased | 230,000,000 | 364,000,000 | 136,000,000 |
| Dividends Paid | 0 | -28,000,000 | -55,000,000 |
| Financing Cash Flow | 1,814,000,000 | 5,000,000 | -548,000,000 |
| Summary | |||
| Free Cash Flow | 2,645,000,000 | 1,703,000,000 | 938,000,000 |
| Net Change in Cash | -449,000,000 | -71,000,000 | -1,036,000,000 |
| Cash Flow Statement (Annual) | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | 1,846,000,000 | 1,592,000,000 | 698,000,000 |
| Depreciation & Amortization | 1,269,000,000 | 1,196,000,000 | 1,136,000,000 |
| Stock Based Compensation | 266,000,000 | 233,000,000 | 220,000,000 |
| Change in Working Capital | -462,000,000 | -770,000,000 | -1,005,000,000 |
| Operating Cash Flow | 3,435,000,000 | 2,503,000,000 | 1,526,000,000 |
| Investing Activities | |||
| Capital Expenditure | -790,000,000 | -800,000,000 | -588,000,000 |
| Investments | -790,000,000 | -711,000,000 | -588,000,000 |
| Investing Cash Flow | -5,687,000,000 | -2,574,000,000 | -2,011,000,000 |
| Financing Activities | |||
| Debt Repayment | 1,827,000,000 | -4,000,000 | -165,000,000 |
| Common Stock Issued/Repurchased | 230,000,000 | 364,000,000 | 136,000,000 |
| Dividends Paid | 0 | -28,000,000 | -55,000,000 |
| Financing Cash Flow | 1,814,000,000 | 5,000,000 | -548,000,000 |
| Summary | |||
| Free Cash Flow | 2,645,000,000 | 1,703,000,000 | 938,000,000 |
| Net Change in Cash | -449,000,000 | -71,000,000 | -1,036,000,000 |